创新药ETF建信(159835)资产负债表
| |
2025-12-31 |
2025-06-30 |
2024-12-31 |
2024-06-30 |
| 资产 |
| 银行存款 |
- |
- |
- |
- |
| 结算备付金 |
203,825.99 |
28,072.09 |
36,744.59 |
8,420.05 |
| 存出保证金 |
201,278.67 |
69,676.74 |
18,141.10 |
18,776.99 |
| 交易性金融资产 |
248,194,878.12 |
104,725,639.55 |
121,743,150.08 |
73,777,914.82 |
| 其中:股票投资 |
248,194,878.12 |
104,725,639.55 |
121,743,150.08 |
73,777,914.82 |
| 债券投资 |
- |
- |
- |
- |
| 资产支持证券投资 |
- |
- |
- |
- |
| 衍生金融资产 |
- |
- |
- |
- |
| 买入返售金融资产 |
- |
- |
- |
- |
| 应收证券清算款 |
855,884.77 |
- |
- |
- |
| 应收利息 |
- |
- |
- |
- |
| 应收股利 |
- |
- |
- |
- |
| 应收申购款 |
- |
- |
- |
- |
| 其他资产 |
- |
75,616.24 |
- |
75,409.12 |
| 资产总计 |
252,473,507.97 |
105,803,971.43 |
124,902,835.23 |
75,682,317.21 |
| 负 债 |
| 短期借款 |
- |
- |
- |
- |
| 交易性金融负债 |
- |
- |
- |
- |
| 衍生金融负债 |
- |
- |
- |
- |
| 卖出回购金融资产款 |
- |
- |
- |
- |
| 应付证券清算款 |
1,031,446.08 |
30,168.46 |
129,677.15 |
- |
| 应付赎回款 |
- |
- |
- |
- |
| 应付管理人报酬 |
108,913.19 |
44,996.68 |
54,322.56 |
31,860.33 |
| 应付托管费 |
21,782.65 |
8,999.34 |
10,864.51 |
6,372.08 |
| 应付销售服务费 |
- |
- |
- |
- |
| 应付交易费用 |
- |
- |
- |
- |
| 应交税费 |
- |
- |
- |
- |
| 应付利息 |
- |
- |
- |
- |
| 应付利润 |
- |
- |
- |
- |
| 其他负债 |
185,388.54 |
107,766.90 |
126,777.29 |
128,783.78 |
| 负债合计 |
1,347,530.46 |
191,931.38 |
321,641.51 |
167,016.19 |
| 所有者权益 |
| 实收基金 |
387,504,143.00 |
171,504,143.00 |
229,504,143.00 |
157,504,143.00 |
| 未分配利润 |
-136,378,165.49 |
-65,892,102.95 |
-104,922,949.28 |
-81,988,841.98 |
| 所有者权益合计 |
251,125,977.51 |
105,612,040.05 |
124,581,193.72 |
75,515,301.02 |
| 负债及所有者权益总计 |
252,473,507.97 |
105,803,971.43 |
124,902,835.23 |
75,682,317.21 |
欢迎访问证券之星!请点此与我们联系 版权所有: Copyright © 1996-年